Rapid target allopurinol concentrations in the hypoxic fetus after maternal administration during labour

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 99, Issue 2, 2014, Pages

  Kaandorp, Joepe J ^a,b   Van Den Broek, M P H ^a   Benders, M J N L ^a   Oudijk, M A ^a   Porath, M M ^c   Oetomo, S Bambang ^c   Wouters, M G A J ^d   Van Elburg, Ruurd ^d,e   Franssen, M T M ^f   Bos, A F ^f   Mol, B W J ^g   Visser, G H A ^a   Van Bel, F ^a   Rademaker, C M A ^a   Derks, J B ^a   De Haan, T R ^h   Boon, J ^h   De Boer, I P ^h   Rijnders, R J P ^h   Jacobs, C J W F M ^h   Scheepers, H C J ^h   Gavilanes, A W ^h   Bloemenkamp, K W M ^h   Rijken, M ^h   Van Meir, C A ^h   Von Lindern, J S ^h   Huisjes, A J M ^h   Bakker, C M J E R ^h   more..

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b DEPARTMENT OF SURGERY   (Netherlands)

^c MÁXIMA MEDICAL CENTER   (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e DANONE RESEARCH   (Netherlands)

^f UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^g ACADEMIC MEDICAL CENTER   (Netherlands)

^h NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALLOPURINOL; DOUBLE-BLIND METHOD; FEMALE; FETAL BLOOD; FETAL HYPOXIA; FETUS; FREE RADICAL SCAVENGERS; FREE RADICALS; HUMANS; HYPOXIA-ISCHEMIA, BRAIN; INFANT, NEWBORN; LABOR, OBSTETRIC; MATERNAL-FETAL EXCHANGE; NEUROPROTECTIVE AGENTS; PLACENTA; PREGNANCY;

EID: 84894061711     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/archdischild-2013-304876     Document Type: Article

References (33)

1. Ferriero DM. Neonatal brain injury. N Engl J Med 2004;351:1985-95.
2. Dirnagl U, Lindauer U, Them A, et al. Global cerebral ischemia in the rat: online monitoring of oxygen free radical production using chemiluminescence in vivo. J Cereb Blood Flow Metab 1995;15:929-40.
3. Gluckman PD, Wyatt JS, Azzopardi D, et al. Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial. Lancet 2005;365:663-70. (Pubitemid 40260887)
4. Shankaran S. Neonatal encephalopathy: treatment with hypothermia. J Neurotrauma 2009;26:437-43.
5. Kaandorp JJ, Benders MJ, Rademaker CM, et al. Antenatal allopurinol for reduction of birth asphyxia induced brain damage (ALLO-trial): a randomized double blind placebo controlled multicenter study. BMC Pregnancy Childbirth 2010;10:8.
6. Fan X, van Bel F. Pharmacological neuroprotection after perinatal asphyxia. J Matern Fetal Neonatal Med 2010; 23:17-19.
7. Miller SL, Wallace EM, Walker DW. Antioxidant therapies: a potential role in perinatal medicine. Neuroendocrinology 2012;96:13-23.
8. Robertson NJ, Tan S, Groenendaal F, et al. Which neuroprotective agents are ready for bench to bedside translation in the newborn infant? J Pediatr 2012;160:544-552.e4.
9. Girard S, Kadhim H, Larouche A, et al. Pro-inflammatory disequilibrium of the IL-1 beta/IL-1ra ratio in an experimental model of perinatal brain damages induced by lipopolysaccharide and hypoxia-ischemia. Cytokine 2008;43:54-62.
10. Hilton GD, Nunez JL, Bambrick L, et al. Glutamate-mediated excitotoxicity in neonatal hippocampal neurons is mediated by mGluR-induced release of ca++ from intracellular stores and is prevented by estradiol. Eur J Neurosci 2006;24:3008-16. (Pubitemid 44952633)
11. Kumar A, Mittal R, Khanna HD, et al. Free radical injury and blood-brain barrier permeability in hypoxic-ischemic encephalopathy. Pediatrics 2008;122:e722-7.
12. van den Tweel ER, Nijboer C, Kavelaars A, et al. Expression of nitric oxide synthase isoforms and nitrotyrosine formation after hypoxia-ischemia in the neonatal rat brain. J Neuroimmunol 2005;167:64-71. (Pubitemid 41242288)
13. Suzuki M, Tabuchi M, Ikeda M, et al. Concurrent formation of peroxynitrite with the expression of inducible nitric oxide synthase in the brain during middle cerebral artery occlusion and reperfusion in rats. Brain Res 2002;951:113-20. (Pubitemid 35253904)
14. Yang L, Sameshima H, Yamaguchi M, et al. Expression of inducible nitric oxide synthase and cyclooxygenase-2 mRNA in brain damage induced by lipopolysaccharide and intermittent hypoxia-ischemia in neonatal rats. J Obstet Gynaecol Res 2005;31:185-91. (Pubitemid 40563044)
15. Saugstad OD. Role of xanthine oxidase and its inhibitor in hypoxia: reoxygenation injury. Pediatrics 1996;98:103-7. (Pubitemid 26226981)
16. Ono T, Tsuruta R, Fujita M, et al. Xanthine oxidase is one of the major sources of superoxide anion radicals in blood after reperfusion in rats with forebrain ischemia/ reperfusion. Brain Res 2009;1305:158-67.
17. Whitelaw A, Thoresen M. Clinical trials of treatments after perinatal asphyxia. Curr Opin Pediatr 2002;14:664-8. (Pubitemid 35333124)
18. Whitelaw A. Systematic review of therapy after hypoxic-ischaemic brain injury in the perinatal period. Semin Neonatol 2000;5:33-40. (Pubitemid 30159176)
19. Palmer C, Vannucci RC, Towfighi J. Reduction of perinatal hypoxic-ischemic brain damage with allopurinol. Pediatr Res 1990;27(4 Pt 1):332-6. (Pubitemid 20114005)
20. Palmer C, Towfighi J, Roberts RL, et al. Allopurinol administered after inducing hypoxia-ischemia reduces brain injury in 7-day-old rats. Pediatr Res 1993;33(4 Pt 1):405-11. (Pubitemid 23095775)
21. Masaoka N, Nakajima Y, Hayakawa Y, et al. Transplacental effects of allopurinol on suppression of oxygen free radical production in chronically instrumented fetal lamb brains during intermittent umbilical cord occlusion. J Matern Fetal Neonatal Med 2005;18:1-7. (Pubitemid 41224356)
22. Graham S, Day RO, Wong H, et al. Pharmacodynamics of oxypurinol after administration of allopurinol to healthy subjects. Br J Clin Pharmacol 1996;41:299-304. (Pubitemid 26114817)
23. Kaandorp JJ, van Bel F, Veen S, et al. Long-term neuroprotective effects of allopurinol after moderate perinatal asphyxia: Follow-up of two randomised controlled trials. Arch Dis Child Fetal Neonatal Ed 2012;97:F162-6.
24. FIGO News. Guidelines for the use of fetal monitoring. Int J Gynecol Obstet 1987;25:159-67.
25. Torrance HL, Benders MJ, Derks JB, et al. Maternal allopurinol during fetal hypoxia lowers cord blood levels of the brain injury marker S-100B. Pediatrics 2009;124:350-7.
26. Boda D, Németh P, Kiss P, et al. Treatment of mothers with allopurinol to produce therapeutic blood levels in newborns. Prenat Neonat Med 1999;4:130-2, 133, 134.
27. Summary of product characteristics acepurin. http://db.cbg-meb.nl/ Bijsluiters/ h09974.pdf. Updated 2012.
28. van Kesteren C, Benders MJ, Groenendaal F, et al. Population pharmacokinetics of allopurinol in full-term neonates with perinatal asphyxia. Ther Drug Monit 2006;28:339-44. (Pubitemid 44314920)
29. Syme MR, Paxton JW, Keelan JA. Drug transfer and metabolism by the human placenta. Clin Pharmacokinet 2004;43:487-514. (Pubitemid 38858303)
30. Stamp LK, Barclay ML, O'Donnell JL, et al. Relationship between serum urate and plasma oxypurinol in the management of gout: Determination of minimum plasma oxypurinol concentration to achieve a target serum urate level. Clin Pharmacol Ther 2011;90:392-8.
31. Derks JB, Oudijk MA, Torrance HL, et al. Allopurinol reduces oxidative stress in the ovine fetal cardiovascular system after repeated episodes of ischemia-reperfusion. Pediatr Res 2010;68:374-80.
32. Kaandorp JJ, Derks JB, Oudijk MA, et al. Antenatal allopurinol reduces hippocampal brain damage after acute birth asphyxia in late gestation fetal sheep. Reprod Sci 2013. doi: 10.1177/1933719113493516
33. Davison JS, Davison MC, Hay DM. Gastric emptying time in late pregnancy and labour. J Obstet Gynaecol Br Commonw 1970;77:37-41.